Clinical Trials Browser

Phase 1 × Glioblastoma × gallium maltolate × Clear all

NCT04319276 2025-11-03

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Phase 1 Active not recruiting

Glioblastoma